Oral treatment for leishmaniasis in older adults
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests if oral medicines can treat cutaneous (skin) or mucosal leishmaniasis in people aged 60 and older. It compares two different pills to find a safer, easier option for elderly patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older and have a confirmed skin or mucosal form of leishmaniasis.
- You have not received leishmaniasis treatment in the last 6 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- Your kidney and liver function tests are within safe limits (not severely elevated).
- You have no serious heart, liver, kidney, or uncontrolled diabetes, and no history of allergic reactions to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
This Phase 3 trial tests whether a high-dose form of amphotericin B made in tiny fat particles (liposomal amphotericin B) is safer and more effective for treating widespread Histoplasmosis in adults with HIV. It may help people who have a serious, whole-body infection caused by Histoplasma.
This trial tests a combination of two medicines—inhaled pentamidine and oral miltefosine—to treat mucosal leishmaniasis, a parasitic infection of the nose, mouth, and throat. It may be an option for people in Bolivia who have not been treated recently.
This trial tests how well miltefosine works for people with leishmaniasis, a skin infection from a parasite. It aims to find the best way to use this medicine to help patients get better.
This study tests different drugs to find which works best for cutaneous leishmaniasis (a skin infection from a parasite). It may help people with many or large sores, or sores in sensitive areas like near the eyes or nose.
This study tests two new oral medicines compared to an existing oral medicine for people with a first episode of cutaneous leishmaniasis (skin sores caused by a parasite). It aims to find a more effective and convenient treatment.
Hear when a new Leishmaniasis; Brazilian trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.